Alexander Colevas
Publication Details
-
Validation that metabolic tumor volume predicts outcome in head-and-neck cancer.
Int J Radiat Oncol Biol Phys. 2012; (5): 1514-20
We have previously reported that metabolic tumor volume (MTV) obtained from pretreatment (18)F-fluorodeoxydeglucose positron emission tomography (FDG PET)/ computed tomography (CT) predicted outcome in patients with head-and-neck cancer (HNC). The purpose of this study was to validate these results on an independent dataset, determine whether the primary tumor or nodal MTV drives this correlation, and explore the interaction with p16(INK4a) status as a surrogate marker for human papillomavirus (HPV).
